Us Bancorp \De\ Kura Oncology, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 7,769 shares of KURA stock, worth $69,998. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,769

Previous 9,179 15.36%

Holding current value

$69,998

Previous $188,000 19.68%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$18.57 - $23.23 $26,183 - $32,754	-1,410 Reduced 15.36%	7,769 $151,000
Q2 2024 Aug 06, 2024	BUY	$17.53 - $22.98 $9,518 - $12,478	543 Added 6.29%	9,179 $188,000
Q1 2024 May 07, 2024	BUY	$13.42 - $23.53 $87,753 - $153,862	6,539 Added 311.83%	8,636 $184,000
Q4 2023 Feb 09, 2024	BUY	$7.58 - $14.38 $4,934 - $9,361	651 Added 45.02%	2,097 $30,000
Q3 2023 Nov 03, 2023	BUY	$8.44 - $11.86 $2,987 - $4,198	354 Added 32.42%	1,446 $13,000
Q2 2023 Aug 09, 2023	BUY	$9.62 - $13.99 $1,991 - $2,895	207 Added 23.39%	1,092 $11,000
Q1 2023 May 09, 2023	SELL	$10.71 - $14.6 $7,882 - $10,745	-736 Reduced 45.4%	885 $10,000
Q4 2022 Feb 13, 2023	BUY	$11.23 - $16.9 $1,987 - $2,991	177 Added 12.26%	1,621 $20,000
Q3 2022 Oct 27, 2022	BUY	$12.01 - $19.45 $15,733 - $25,479	1,310 Added 977.61%	1,444 $20,000
Q2 2022 Aug 01, 2022	SELL	$10.71 - $18.33 $5,140 - $8,798	-480 Reduced 78.18%	134 $2,000
Q1 2022 May 11, 2022	BUY	$11.78 - $16.98 $7,232 - $10,425	614 New	614 $10,000
Q4 2021 Feb 11, 2022	SELL	$12.22 - $19.57 $10,350 - $16,575	-847 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$15.42 - $21.72 $8,434 - $11,880	547 Added 182.33%	847 $16,000
Q2 2021 Aug 05, 2021	BUY	$20.85 - $29.88 $5,921 - $8,485	284 Added 1775.0%	300 $7,000
Q1 2021 Apr 28, 2021	SELL	$24.75 - $39.14 $1,509 - $2,387	-61 Reduced 79.22%	16 $0
Q4 2020 Feb 04, 2021	BUY	$29.0 - $41.62 $2,233 - $3,204	77 New	77 $3,000

Others Institutions Holding KURA

# of Institutions

185

Shares Held

81.8M

Call Options Held

42.1K

Put Options Held

34K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $603M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account